🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized, double-blind, placebo-controlled, multi-center,...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT03532958
Treatments Being Tested
The main purpose of this study is to evaluate the safety and efficacy of on...
Status
Completed
Location
The Second People's Hospital of Hefei
Start Date
2020-12-07
Trial ID
NCT04591626
Treatments Being Tested
Primary Objective: To evaluate, in comparison with placebo, the efficacy o...
Status
Completed
Location
Investigational Site Number 8400006
Start Date
2016-12-21
Trial ID
NCT02921971
This study is to evaluate the efficacy and safety of AK104 plus concurrent ...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2022-06-21
Trial ID
NCT05235516
Primary study objective: To confirm the efficacy of HBM9161 subcutaneous in...
Status
Completed
Location
Huashan Hospital, Fudan University
Start Date
2021-09-25
Trial ID
NCT05039190
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy, safety, and ...
Status
Active Not Recruiting
Location
Site Number - 1010
Start Date
2025-02-19
Trial ID
NCT06980805
Primary objective: \- to evaluate the efficacy of Sarilumab in participant...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2010-02
Trial ID
NCT01061723
This sponsor-open, investigator- and participant-blinded, multi-center stud...
Status
Completed
Location
Gastroenterology department, Second clinic of internal diseases
Start Date
2016-12-12
Trial ID
NCT02956850
This is a phase 2, randomized, placebo controlled, multi-center study to es...
Status
Completed
Location
Research Site
Start Date
2007-07
Trial ID
NCT00511459
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled ,...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2026-02-24
Trial ID
NCT07394114
Treatments Being Tested